Kevin Tan

Filings by Kevin Tan span 2 companies, the busiest being Solid Biosciences Inc. and Cartesian Therapeutics, Inc. Between 2 December 2021 and 13 February 2026, the trades on record add up to 9 filings.

On the open market, the record shows 1 purchase worth €13k and 1 sale worth €81k. On balance, insiders were net sellers of €67k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 6 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

Most recently, on 18 February 2026, the filings show an option exercise in Solid Biosciences Inc. The most recent open-market purchase was published on 6 December 2021, 1,777 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.